Rosenthal T, Shani M, Peleg E, Harnik M
Hypertension Unit, Chaim Sheba Medical Center, Tel Hashomer, Israel.
Am J Hypertens. 1988 Jul;1(3 Pt 3):49S-52S. doi: 10.1093/ajh/1.3.49s.
Hypertensinogenic properties of recently synthesized 18-OH-19-nor-B and the related 18-OH-B were examined in adrenalectomized, spontaneously hypertensive rats (SHR). Each steroid was given via Alzet miniosmotic pump (2002), with and without aldosterone. Neither 18-OH-19-nor-B (5 micrograms) nor 18-OH-B (5 micrograms) increased blood pressure in SHR when given alone, but when administered together with aldosterone (5 micrograms), which was ineffective by itself, resulted in a significant rise in blood pressure. There is a high probability that certain mineralocorticoids, which are inactive by themselves, are of importance in the etiology of hypertension under physiological conditions.
在肾上腺切除的自发性高血压大鼠(SHR)中检测了最近合成的18-羟基-19-去甲-B及其相关的18-羟基-B的致高血压特性。每种类固醇通过Alzet微型渗透泵(2002型)给药,分别在有和没有醛固酮的情况下。单独给予18-羟基-19-去甲-B(5微克)或18-羟基-B(5微克)时,均不会使SHR的血压升高,但与本身无效的醛固酮(5微克)一起给药时,则会导致血压显著升高。某些本身无活性的盐皮质激素在生理条件下的高血压病因中具有重要作用,这种可能性很大。